Details for New Drug Application (NDA): 062311
✉ Email this page to a colleague
NDA 062311 describes AMIKIN, which is a drug marketed by Apothecon and is included in four NDAs. Additional details are available on the AMIKIN profile page.
The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
Summary for 062311
| Tradename: | AMIKIN |
| Applicant: | Apothecon |
| Ingredient: | amikacin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062311
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
